References
- Centers for Disease Control and Prevention, USA. Update: Staphylococcus aureus with reduced susceptibility to vancomycin in United States, Morbidity and Mortality Weekly, 1997; 6: 813–815.
- Leopold, A. (1949). A Sand Country Almanac. New York: Ballantine Books. 1966: 32.
- Fleming, A. quoted In: Zimmer, C. Evolution-the Triumph of an Idea. New York: Harper Collins. 2001: 214.
- Ehrenfeld, D. The Arrogance of Humanism. New York and Oxford: Oxford University Press. 1981: 127.
- Burnet, F. M. Natural History of Infectious Disease, 3rd Edition. Cambridge: Cambridge University Press. 1962: 3.
- Vogel, L. (ed.). Hans Jonas: Mortality and Morality: A Search for the Good After Auschwitz. Evanston, Illinois: Northwestern University Press. 1996: 6.
- Capron, A. M. Which ills to bear? Revaluating the ‘threat’ of modern genetics. In: T. Shannon(ed.). Bioethics. New Jersey: Paulist Press. 1993: 488–516.
- Rifkin, J. The Biotech Century: Harnessing the Gene and Remaking the World. New York: J. P. Tarcher Publishing. 1999: 7.
- Levy, S. B. The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle, 2nd Edition. Boston, Massachusetts: Persus Books. 2002: 114–304.
- Levy, S. B., J. Burke, E. Wallace(eds.). Antibiotic use and antibiotic resistance worldwide. Infectious Disease Review, 8: (Supplement 3). 1987: 22–26.
- American Society of Microbiology. Report of the ASM task force on antibiotic resistance. Washington, D.C.: The Society's Public and Scientific Affairs Board Press. 1994.
- Brundtland, G. H. WHO/UATLD Global Project on Anti-Drug resistance Surveillance 1997–2000. WHO Report Number 2.(cited January 2001). Available at: http://www.who/cds/tb/2000.